Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 févr. 2026 08h30 HE | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement

Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite no difference in platelet count recovery End-of-Phase...
20 févr. 2026 08h30 HE | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands...
18 févr. 2026 11h26 HE | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Report December 2025: Trump Administration Sets Deadline for Pharma Companies to Fulfill MFN Commitments/UK-US Tariff Deal and Pricing Reforms Position UK As Global Hub

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, December 2025" report has been added to ResearchAndMarkets.com's offering.The Bio/Pharmaceutical Outsourcing...
10 févr. 2026 16h30 HE | Source: Custom Market Insights

[Latest] Global Large And Small Scale Bioprocessing Market Size/Share Worth USD 277.4 Billion by 2035 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Large And Small Scale Bioprocessing Market Size, Trends and Insights By Scale...
29 janv. 2026 04h06 HE | Source: Research and Markets

Chemistry, Manufacture and Control (CMC) Regulatory Requirements for Biological Drug Products Training Course (Online Event: Apr 23rd - Apr 24th, 2026)

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products Training Course (Apr 23rd - Apr 24th, 2026)" training...
26 janv. 2026 04h15 HE | Source: Research and Markets

Spine Biologic Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Spine Biologic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
22 janv. 2026 11h34 HE | Source: Research and Markets

Microbiome Sequencing Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Microbiome Sequencing Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
12 janv. 2026 11h22 HE | Source: Research and Markets

Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns

Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market: Industry Trends and Global Forecasts, Till 2040 - Distribution by Type of Peptide, Route of Administration, Key...
12 janv. 2026 08h00 HE | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibitor

SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current...
06 janv. 2026 09h07 HE | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Market Research Report, November 2025: Transforming US Drug Access and Production - MFN Pricing Deals and Historic Manufacturing Investments

Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, November 2025" report has been added to ResearchAndMarkets.com's offering.The Bio/Pharmaceutical Outsourcing...

Page suivante